Form 4: Agenus Inc. Executive Receives Stock for Salary

Agenus Inc. reports that Garo H. Armen, Director and Officer, received 4,644 shares of common stock valued at $3.50 per share as compensation for his salary.

Summary

• Garo H. Armen, a Director and Officer of Agenus Inc., received 4,644 shares of common stock on May 29, 2026.
• These shares were issued in lieu of cash salary, as approved by the Agenus Inc. Compensation Committee.
• The value of the shares is based on the closing price of $3.50 per share on May 29, 2026.
• Following this transaction, Mr. Armen directly beneficially owns 355,967 shares.
• Additionally, he indirectly beneficially owns 31,298 shares held in his IRA accounts and 28,950 shares held by Pixie Partners, where he is a general partner.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction for executive compensation rather than a significant strategic development or financial performance indicator.

Positives

• Executive compensation structure aligns with company stock, potentially demonstrating confidence in future growth.
• The transaction was approved by the Compensation Committee, indicating adherence to corporate governance procedures.
• Shares are fully vested upon issuance, providing immediate benefit to the executive.

Negatives

• The company is paying executive salaries in stock, which could suggest cash flow constraints or a strategic decision to conserve cash.
• The stock price of $3.50 per share may be considered low by some investors, depending on historical performance and industry benchmarks.

Risks

• The reliance on stock for salary payments could be impacted by future stock price volatility.
• Potential for dilution of existing shareholders if a significant portion of executive compensation is paid in stock over time.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. However, the use of stock for salary suggests management's belief in the company's future value.

Management Comments

• At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash.
• The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 29, 2026.
• Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

Industry Context

StockSavvy.ai notes that the practice of paying executive salaries in stock is common in the biotechnology and pharmaceutical sectors, particularly for early-stage or growth-oriented companies aiming to conserve cash and align executive interests with shareholders.

Related Party Transactions

• Garo H. Armen's salary being paid in stock, approved by the Compensation Committee.

Stakeholder Impact

• Shareholders: Potential for slight dilution if this practice becomes widespread; alignment of executive interests with stock performance.
• Employees: May signal a company culture that prioritizes equity and long-term growth.
• Management: Direct financial benefit tied to stock value.

Next Steps

• Continued monitoring of Agenus Inc.'s stock performance and future insider transactions.
• Analysis of subsequent SEC filings for further insights into executive compensation and company strategy.

Key Dates

Keywords

Agenus Inc., Garo H. Armen, Form 4, Stock Compensation, Insider Transaction, Executive Salary, Beneficial Ownership, SEC Filing